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Abstract: The condensation reaction of 4-benzylidene-2-p-tolyloxazol-5(4H)-one(2) with 2-amino 
substituted benzothiazole3(I-VI) was yielded a series of 4-benzylidene-1-(substitued-2-benzo thiazolyl)-2-(4-
methoxyphenyl)-1H-imidazol-5(4H)-one 4(I-VI).The 4-benzylidene-2-p-tolyloxazol-5(4H)-one(2) has been 
prepared from cyclo condensation reaction between hippuric acid (1) with p-methyl benzaldehyde. The 
novel prepared compounds were characterized by IR, 1H-NMR, 13C-NMR and Mass spectral data. All the 
prepared compounds were screened for their antibacterial activities and antifungal activities. 
Keywords:  2-amino benzthiazole; Antibacterial activities; Antifungal activities; Imidazole. 
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INTRODUCTION  
 
In recent years, antimicrobials are one of a very significant class of drug. Because these classes of 
drugs are prescribed exact from an uncomplicated disease to the serious diseases like cancer. The 
chemistry of heterocyclic compounds has been an interesting field of study for a long time. Majority of the 
drugs being introduced in pharmacopeias every year are heterocyclic compounds. Sulphar and nitrogen 
containing heterocyclic compounds represent an important class of drugs in the therapeutic chemistry and 
also contributed to the society from biological and industrial point which helps to understand life processes 
(Patel and Shaikh, 2010; Shah, 2012) The synthesis of novel imidazolo quinoline analogs and investigation 
of their chemical and pharmacological behavior have gained more importance in recent decades for 
medicinal reasons (Raghavendra et al., 2011). Imidazole derivatives including saturated imidazoles are 
important heterocycles due to their antibacterial, antitubercular, antifungal, antiHIV, antiinflammatory, 
analgesic,anticancer and anticonvulsant activities (Shalini et al., 2010; Husain et al., 2009; Robert  et 
al.,2010; Neves  et al.,2010; Sharma and Khan,2001; Khan and Chawla,2002; Khan and Gupta,2003). 
They have also been utilized as a versatile template for the synthesis of compounds with potential enzyme 
inhibition activities (Patel et al., 2004). Benzothiazole is one of the most important heterocycle that has 
received overwhelming response owing to its diversified molecular design and remarkable optical, liquid 
and electronic properties (Ha et al., 2009). Benzothiazole shows various biological activities such as 
antimicrobial (Gupta et al., 2009; Kumbhare and Ingle, 2009; Murthi anf Pathak, 2008; Rajeeva et al., 2009; 
Maharan et al., 2007), anticancer (Stanton et al., 2008), anthelmintic (Sreenivasa et al.,2009), anti-diabetic 
(Pattan et al., 2005) activities. Hence, it was thought of interest to merge both of thiazole and imidazole 
moieties which may enhance the drug activity of compounds to some extent or they might possess some of 
the above mentioned biological activities. From this point of view, the objective of the present work is to 
prepare new derivatives of Imidazole- benzothiazole containing moiety. Hence the current communication 
contains the study on novel 4-benzylidene-1-(substitued-2-benzothiazolyl)-2-(p-tolyl)-1H-imidazol-5(4H)-
one 4(I-VI) (Figure 1). 
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EXPERIMENTAL 
 
  All the chemicals used were of analytical grade. The IR spectra were recorded in KBr pellets on a 
Nicolet 400D spectrometer and 1H NMR and 13C NMR spectra were recorded in DMSO with TMS as 
internal standard on a Bruker spectrometer at 400 MHz and 100 MHz, respectively. LC-MS of selected 
samples was taken on LC-MSD-Trap-SL_01046. Melting points were determined in open capillary tubes 
and were uncorrected. 
Synthesis of 4-benzylidene-2-p-tolyloxazol-5(4H)-one (2): The mixture of hippuric acid(1) (0.1mole), p-
methyl benzaldehyde (0.1mole), anhydrous sodium acetate (0.1mole) and acetic anhydride (0.2mole) warm 
on water bath with occasional stirring until solution is complete. Boil the resulting solution for 2 hrs, cool to 
0-5oC. Stir the yellowish brown solid product with water. The solid separated was collected by filtration, 
washed with ether, dried and recrystallized from ethyl acetate The yield of the product was 76 % and the 
product melts at 172-173oC. For C17H13NO2(263) Calcd.: %C,77.55;%H,4.98;%N,5.32,Found: % C, 77.5; 
%H, 4.9;%N, 5.3.IR (KBr); (cm-1): 3080 (Aromatic C-H stretch), 2848(CH3),760(Aromatic C-H 
bending),1620-1580(Aromatic C-C stretch), 1790 (C=O lacton), 1650(C=N),1260(C-N). 1 H NMR: 8.08–
7.12(9H,m) (Ar-H), 7.98 (1H,s) (C=CH), 2.35(3H,s) (CH3). 13C NMR: 166.4 (CO lacton), 163.3-114.6 (Ar-
12C), 161.3 (C=N), 131.9, 112.7 (C=C), 21.7(CH3). 
Synthesis of 2-amino-4-substitued benzothiazoles 3(I-VI): The solution of substituted aniline (0.2 mole) 
and potassium thiocyanate (0.8 mole) in glacial acetic acid was added drop wise to 20% bromine glacial 
acetic acid (0.2 mole) with stirring, while the temperature was kept below 35oC. After all the bromine 
solution had been added. The mixture was stirred for 9-11 hrs, then filtered and the residue washed with 
water. The combined filtrate and washings were neutralized with ammonium hydroxide. The precipitate was 
collected on a filter and dried. The yields, melting points and other characterization data of these 
compounds are given in Table 1. 
Synthesis of 4-benzylidene-1-(substitued-2-benzothiazolyl)-2-(p-tolyl)-1H-imidazol-5(4H)-one 4(I-VI): 
A mixture 4-benzylidene-2-p-tolyloxazol-5(4H)-one (2)(0.01mole) and 2-amino-4-substituted benzothiazoles 
3(I-VI) (0.01mole) was refluxed in presence of pyridine for 6-8 hours. Excess of pyridine was distilled off 
and resulting mass was poured on to crushed ice and neutralized with acid, filtered and crystallized from 
ethanol. The yields, melting points and other characterization data of these compounds are given in Table-
2. 
 
BIOLOGICAL SCREENING 
Antibacterial activity: The antibacterial activities of all the compounds were studied against gram-positive 
bacteria (Staphylococcus aureus and Bacillus subtilis) and gram-negative bacteria (E.coli, and klebsiella 
promioe) at a concentration of 50μg/ML by agar cup plate method. A methanol system was used as control 
in this method. Similar conditions using tetracycline as a control was used standard for comparison. The 
area of inhibition of zone measured in mm. Compounds 3(III), 3(V), 4(III) and 4(V) were found more toxic 
for microbes. Other compounds found to be less or moderate active than tetracycline Table -3 and 
represented in figure 1. 
Antifungal activity: The fungicidal activity of all the compounds was studied at 1000 ppm concentration in 
vitro. Plant pathogenic organisms used were Nigrospora sp, Aspergillus niger, Botrydepladia thiobromine, 
and Rhizopus nigricum, Fusarium oxyporium. The antifungal activity of all the compounds (3(I-VI)) and (4(I-
VI)) were measured on each of these plant pathogenic strains on a potato dextrose agar (PDA) medium. 
Such a PDA medium contained potato 200g, dextrose 20g, agar 20g and water 1cc. Five days old cultures 
were employed. The compounds to be tested were suspended (1000ppm) in a PDA medium and 
autoclaved at 120o C for 15 min. at 15atm. pressure. These media were poured into sterile petri plates and 
the organisms were inoculated after cooling the Petri plates. The percentage inhibition for fungi was 
calculated after five days using the formula given below: 
Percentage of inhibition = 100(X-Y) / X 
     Where,    X = Area of colony in control plate 
                    Y = Area of colony in test plate Shah 2014; Studies of Novel Thiazole-Imidazole Combined Molecule 
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The fungicidal activity displayed by various compounds 3(I-VI) and 4(I-VI) are shown in Tables-4 and 
represented in figure 2. 
 
RESULTS AND DISCUSSION 
 
  In present communication the condensation reaction between hippuric acid (1) with p-methyl 
benzaldehyde gives 4-benzylidene-2-p-tolyloxazol-5(4H)-one (2). The structures of (2) were confirmed by 
elemental analysis and IR spectra showing an absorption band at 3080(Aromatic C-H stretch), 
2848(CH3),760(Aromatic C-H bending),1620-1580(Aromatic C-C stretch), 1790(C=O lacton), 1650 
(C=N),1260(C-N); 1 H NMR: 8.08–7.12(9H,m) (Ar-H), 7.98 (1H,s) (C=CH), 2.35(3H,s) (CH3).  13C NMR: 
166.4 (CO lacton), 163.3-114.6 (Ar-12C), 161.3 (C=N), 131.9,112.7 (C=C),21.7(CH3). For C17H13NO2(263) 
Calcd.: %C,77.55;% H,4.98;  %N,5.32,Found: % C, 77.5; %H, 4.9;%N, 5.3. The structures assigned to 2-
amino substituted benzothiazole 3(I-VI)  were supported by the elemental analysis and IR spectra showing 
absorption bands at 3475cm-1(NH2), 3030-3080cm-1(Aromatic C-H stretch),1542cm-1(Aromatic C=C),1560 
cm-1(C=N),615cm-1(C-S),1120cm-1(OCH3),1452cm-1(NO2), 686 cm-1(Aromatic C-Cl),1076cm-1(Aromatic C-
Br);1H NMR:7.06 (2H,s) (-NH2), 3I:8.20-7.65(4H,m)(Ar-H), 3II: 8.02-7.40(3H,m)(Ar-H),2.46(3H,s) (-
CH3),3III:8.22-7.60(3H, m) (Ar-H), 3IV: 8.80-7.70(3H,m) (Ar-H),3V:7.60 -7.10(3H,m) (Ar-H),3VI:8.70-
8.20(3H,m)(Ar-H);13CNMR: 166.8 (C=N),3I:153.6,131.4, 125.6,124.8, 122, 118.8 (Ar-
C),3II:150.4,134.3,131.2,126.8, 121.5 (Ar-C),21.2(CH3),3III:151.6,132.8,130.2, 126, 121.4,118.5 (Ar-C), 
3IV: 152.4, 133.2,129,124.3,119.2,117.4(Ar-C), 3V: 157.2, 145.8, 132.4, 118.6, 114.8,105.6(Ar-C), 3VI: 
159.6, 144.8, 131.5, 121.6,119.5,117.8 (Ar-C). The C, H, N, S analysis data of all compounds are 
presented in Table-1. 
  IR spectra of 3(I-VI) are almost resemble those of the corresponding 4(I-VI) only discernable 
variation observed that the bend at 3475cm-1(NH2) is absent and the new bands at 3080(Aromatic C-H 
stretch), 2848(CH3),760(Aromatic C-H bending),1620-1580(Aromatic C-C stretch), 1790(C=O lacton), 1650 
(C=N),1260(C-N) are observed in all the spectra of 4(I-VI),  which might be responsible for formation of 
imidazole ring systems.1H NMR: 7.63-7.09 (9H,s)(Ar-H),7.45(1H,s)(CH=C),2.35-2(3H,s) (CH3).4I: 8.25-7.59 
(4H,m) (Ar-H),4II:7.932-7.35(3H,m)(Ar-H),2.42(3H,s)(-CH3),4III:7.57-7.03(3H,m)(Ar-H),1.32(CH3), 4IV:8.67-
8.06(3H,m)(Ar-H),4V:8.18-7.57(3H,m)(Ar-H),4VI:8.76-7.69(3H,m)(Ar-H);13CNMR:139.7,135.4,130.2,129.3 , 
129.3,128.9,128.9,128.9,128.8,128.7,128.5,128.3(Ar-C),130.6,114.7(C=C),170.4(C=Oimidazole ring),158.1 
(C=N),160.3(C=Nbenzothiazole ring),21.7 (CH3), 4I:139.7,135.5, 125.4,124.8,122.2,118.6(Ar-C),4II: 147.3, 
131.4,126.8,126.2,124.7, 119.2 (Ar-C), 16.5 (CH3),4III: 150.3,142.6,132.3, 122.1,114.4,105.5 (Ar-C), 56.1 
(OCH3),4IV:145.2,142.2,128.3,125.9,125.5,122.7(Ar-C),4V:149.4,132.6,126.1,122.2,121.8,120.3(Ar-C),4VI: 
151.7,128.8,128.5,126.8,121.2,116.7(Ar-C).The C,H,N,S analysis data of all compounds are presented in 
Table 2.   
  The examination of elemental analytical data reveals that the elemental contents are consistence 
with the predicted structure shown in Scheme-1. The IR data also direct for assignment of the predicted 
structure. The final structure of all compounds is confirmed by LC-MS. LC-MS data of all compounds are 
presented in Tables 1 and 2. 
Table 1. Analytical Data and Elemental Analysis of Compounds 3(I-VI)   
Compd.  Molecular 
formula 
(Mol.wt.) 
LC-
MS 
Data 
M.P.* 
0C  Yield 
Elemental Analysis 
%C %H %N %S 
  Calcd. Found Calcd. Found Calcd. Found Calcd. Found 
3I  C7H6N2S 
(150)  169  159-
161  72 55.97 55.9  4.03  4.0  18.65 18.6 21.35 21.3 
3II  C8H8N2S 
(164)  178  162-
164  67 58.51 58.4  4.91  4.8  17.06 17.0 19.52 19.5 
3III  C8H8N2OS 
(180)  196  153-
156  64 53.31 53.2  4.47  4.4  15.54 15.5 17.79 17.7 
3IV  C7H5N3O2S 
(195)  212  156-
158  68 43.07 43.0  2.58  2.5  21.53 21.5 16.43 16.4 Shah 2014; Studies of Novel Thiazole-Imidazole Combined Molecule 
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*Uncorrected 
Table 2. Analytical Data and Elemental Analysis of Compounds 4(I-VI) 
         *Uncorrected 
Table 3. Antibacterial Activity of Compounds 
Compounds  Gram +Ve  Gram -Ve 
Staphylococcus aureus  Bacillus subtilis E.coli  Klebsiella  promioe 
3I 52  51  59  61 
3II 51  57  54  64 
3III 62  68  71  73 
3IV 50  57  69  65 
3V 55  65  70  78 
3VI 53  59  67  70 
4I 52  56  67  67 
4II 55  57  58  61 
4III 76  77  81  80 
4IV 68  73  77  75 
4V 54  74  69  73 
4VI 64  67  62  61 
Tetracycline   55  79  74  84 
 
Table 4. Antifungal Activity of Compounds 
Zone of Inhibition at 1000 ppm (%) 
Compounds  Nigrospora 
Sp. 
Aspergillus 
Niger 
Botrydepladia 
Thiobromine 
Rhizopus 
Nigricum 
Fusarium 
oxyporium 
3I 65  62  62  56  68 
3II 57 51  59  64  61 
3III 72 69  71  72  75 
3IV 65 65  62  61  60 
3V 67 65  63  76  72 
3VI 61 59  61  65  70 
4I 65  63  64  61  60 
4II 64 61  56  62  55 
4III 75 69  74  65  66 
4IV 60 65  66  62  61 
3V  C7H5N2OSCl 
(183)  199  153-
155  70 45.53 45.5  2.73  2.7  15.17 15.1 17.37 17.3 
3VI  C7H5N2OSBr 
(229)  238  161-
163  67 36.70 36.6  2.20  2.1  12.23 12.2 14.00 13.9 
Compd.  Molecular 
formula 
(Mol.wt.) 
LC-
MS 
Data 
M.P.* 
0C  Yield 
Elemental Analysis 
%C %H %N %S 
  Calcd. Found Calcd. Found Calcd. Found Calcd. Found 
4I  C24H17N3O2S 
(411)  426  192-
194  70 70.05  70.0 4.16  4.1 10.21  10.1 7.79  7.7 
4II  C25H19N3O2S 
(425)  438  194-
196  64  70.57  70.5  4.50 4.4 9.88 9.8 7.54 7.5 
4III  C25H19N3O3S 
(441)  460  203-
205  65  68.01  68.0  4.34 4.3 9.52 9.5 7.26 7.2 
4IV  C24H16N4O4S 
(456)  477  198-
199  58 63.15  63.1 3.53 3.53  12.27  12.2 7.02  7.0 
4V  C24H16N3O2SCl 
(445)  462  194-
195  56  64.64  64.6  3.62 3.6 9.42 9.4 7.19 7.1 
4VI  C24H16N3O2SBr 
(489)  497  207-
209  59  58.78  58.7  3.29 3.2 8.57 8.5 6.54 6.5 Shah 2014; Studies of Novel Thiazole-Imidazole Combined Molecule 
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4V 66 68  68  65  67 
4VI 61 65  62  58  62 
 
 
 
Figure 1. Structure of 4-benzylidene-1-(substitued-2-benzothiazolyl) 
-2-(p-tolyl)-1H-imidazol-5(4H)-one 
 
CONCLUSION 
 
  In conclusion, novel 4-benzylidene-1-(substitued-2-benzothiazolyl)-2-(p-tolyl)-1H-imidazol-5(4H)-
ones has been synthesized by an extremely efficient process. All the novel synthesized compounds show 
moderate to excellent antibacterial and antifungal activities. 
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